Leggett & Platt

LEG · NYSE

$9.20−$0.12 (−1.29%)TodayMarket closed · Aug 26, 7:32 PM ET

No price history for this range.

LEG analyst rating

HoldConsensus of 2 analysts over the last 12 months. 0% rate it a buy.

Strong buy0
Buy0
Hold2
Underperform0
Sell0

12-month price target · 2 analysts

Average $10.20 (+10.9% upside)

Low: $10.10
Now: $9.20
High: $10.50

Upgrades and downgrades

The latest rating actions, newest first

LEG analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Piper Sandler	Aug 12, 2026	Maintains	Neutral	$12.00 → $10.00	59%
Truist Securities	May 8, 2026	Maintains	Hold	$13.00 → $11.00	53%
Piper Sandler	Dec 11, 2025	Maintains	Neutral	$10.00 → $12.00	59%
Truist Securities	Oct 29, 2025	Maintains	Hold	$10.00 → $12.00	53%
Piper Sandler	Oct 29, 2025	Maintains	Neutral	$9.00 → $10.00	59%

The case for and against

Updated Apr 17, 2026

Bull case

Leggett & Platt Inc. has demonstrated a positive financial trajectory, with Adjusted EBITDA margins increasing by 210 basis points to 9.9%, largely driven by restructuring savings. The company's bedding sales reported a sequential improvement of 3% in the second quarter, indicating robust demand and an optimistic outlook, as management reaffirmed revenue projections and highlighted impressive category-specific gains within the Bedding segment. Additionally, a notable reduction in the net leverage ratio to 2.6x from 3.8x over the past year further underscores Leggett & Platt's enhanced financial stability and capacity for long-term growth driven by an enticing innovation pipeline.

Bear case

Leggett & Platt Inc has encountered significant challenges, particularly in its Bedding Products segment, which experienced a 10% year-over-year sales decline primarily due to a 13% drop in volumes, exacerbated by ongoing retailer merchandising changes affecting key customers. The Specialized Products segment also reported a 7% decline in revenues, driven by weakened Steel Rod sales and overall volume decreases, indicating broader struggles within the company. Consequently, the outlook for earnings per share has been revised downward for both 2025 and 2026, reflecting a cautious view on the company's ability to recover amidst ongoing market pressures.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.